Is SBBP or QYLD a better dividend investment in 2026?

SBBP currently yields 100.00% with a 5% 5-year dividend growth rate. QYLD yields 12.24% with -2.1% growth. The better choice depends on your goal: SBBP offers higher current income.

What is the dividend yield difference between SBBP and QYLD?

SBBP has a forward dividend yield of 100.00% ($2.00/share annually). QYLD yields 12.24% ($2.04/share annually). The yield gap is 87.76 percentage points.

Home › Compare › SBBP vs QYLD

SBBP vs QYLD: Dividend Comparison 2026

SBBP yields 100.00% · QYLD yields 12.24%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SBBP wins by $3.87M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SBBP

● Live price

100.00%

Share price

$2.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3.90M

Annual income

$1,312,946.05

Full SBBP calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

12.24%

Share price

$16.70

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$6,038.84

Full QYLD calculator →

Portfolio growth — SBBP vs QYLD

📍 SBBP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SBBP	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SBBP + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SBBP pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SBBP

Annual income on $10K today (after 15% tax)

$8,500.00/yr

After 10yr DRIP, annual income (after tax)

$1,116,004.14/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,040.82/yr

After 10yr DRIP, annual income (after tax)

$5,133.01/yr

At 15% tax rate, SBBP beats the other by $1,110,871.13/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SBBP + QYLD for your $10,000?

SBBP: 50%QYLD: 50%

100% QYLD50/50100% SBBP

Portfolio after 10yr

$1.96M

Annual income

$659,492.44/yr

Blended yield

33.63%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBBP right now

SBBP

Analyst Ratings

Buy

Hold

Consensus: Buy

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SBBP buys

QYLD buys

No recent congressional trades found for SBBP or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSBBPQYLD

Forward yield	100.00% ✓	12.24%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$3.90M	$26.5K ✓
Annual income after 10y	$1,312,946.05 ✓	$6,038.84
Total dividends collected	$3.48M	$28.5K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: SBBP vs QYLD ($10,000, DRIP)

Year	SBBP Portfolio	SBBP Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$20,700	$10,000.00	$10,384	$1,224.49	+$10.3K → SBBP
2	$41,495	$19,345.79	$10,900	$1,388.18	+$30.6K → SBBP
3	$80,643	$36,243.16	$11,576	$1,590.76	+$69.1K → SBBP
4	$152,116	$65,828.38	$12,447	$1,844.20	+$139.7K → SBBP
5	$278,813	$116,048.53	$13,567	$2,164.97	+$265.2K → SBBP
6	$497,119	$198,789.52	$15,003	$2,576.05	+$482.1K → SBBP
7	$863,169	$331,251.38	$16,853	$3,110.04	+$846.3K → SBBP
8	$1,461,129	$537,538.09	$19,251	$3,813.85	+$1.44M → SBBP
9	$2,413,798	$850,390.15	$22,390	$4,756.08	+$2.39M → SBBP
10	$3,895,710	$1,312,946.05	$26,548	$6,038.84	+$3.87M → SBBP

SBBP vs QYLD: Complete Analysis 2026

SBBP — Stock

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.

Full SBBP Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this SBBP vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SBBP vs SCHD SBBP vs JEPI SBBP vs O SBBP vs KO SBBP vs MAIN SBBP vs XYLD SBBP vs JEPQ SBBP vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.